Boston Judge Halts RFK Jr.'s Vaccine Push, Blocks Key Policies
Boston Judge Halts RFK Jr.'s Vaccine Push, Blocks Key Policies
A federal court blocks major parts of RFK Jr.'s vaccine agenda, signaling ongoing debate over U.S. immunization policy.
A federal judge in Boston halted major parts of Health and Human Services Secretary Robert F. Kennedy Jr.’s sweeping moves to upend U.S. immunization policies, including his push to cut the number of vaccines routinely recommended for children and to disband and reconstitute a key vaccine advisory committee. The ruling, issued on March 16, 2026, marks a significant setback for Kennedy’s effort to reshape how vaccines are recommended and reviewed in the United States. By blocking these moves, the court preserves the status quo for now while underscoring the court’s view that policy changes of this scale require more formal process and evidence.
The decision was handed down by U.S. District Judge Brian Murphy in Massachusetts. He sided with medical groups who argued that Kennedy and the agencies he oversees unlawfully reshaped federal policies in ways that could raise barriers to vaccination and undermine public trust in vaccines. The judge blocked the CDC’s attempt to reduce the number of shots and also ruled against Kennedy’s plan to disband and reconstitute a key vaccine advisory committee, prompting the postponement of a scheduled meeting. Kennedy, a longtime anti-vaccine activist appointed by the previous administration, has faced skepticism from public health experts who say his approach could jeopardize immunization coverage and scientific consensus.
Murphy’s decision adds to a string of federal rulings that have limited Kennedy’s policy initiatives and kept certain health-administration reforms in limbo. He is a Biden appointee who has previously authored rulings on immigration and other energy issues, and his opinion in this vaccine matter reflects a broader judicial emphasis on following established processes and evidence when altering national public health guidance. The atmosphere surrounding these rulings has been tense, with supporters arguing for more flexible, safety-focused policy shifts and opponents warning that rapid changes can erode public trust in vaccines.
Experts say the ruling could shape the trajectory of U.S. immunization policy for years, potentially slowing or halting Kennedy’s broader reform agenda while keeping vaccine guidance grounded in longer, more transparent review. Public health groups have welcomed the decision as a check on politically charged reform but cautioned that the dispute will continue to reverberate through vaccination practices, parental decisions, and trust in health authorities. Looking ahead, the court’s decision leaves several Kennedy-driven proposals in limbo, and advocates on both sides say ongoing legal and administrative battles are likely as the nation seeks to balance scientific evidence with public concerns.
